Status:

TERMINATED

Aspirin and Antiretroviral Therapy in HIV Infected Patients

Lead Sponsor:

Hennepin Healthcare Research Institute

Conditions:

HIV Infection

Eligibility:

All Genders

18-60 years

Phase:

PHASE2

Brief Summary

The purpose of this study is to examine the effects of HIV treatment (antiretroviral therapy) and aspirin use on risk for cardiovascular disease among HIV infected persons.

Detailed Description

Cardiovascular disease is now a major health concern among persons with HIV infection. Our general hypothesis is that HIV-mediated inflammation and injury to vascular surfaces up-regulates thrombotic ...

Eligibility Criteria

Inclusion

  • HIV-infected (by positive HIV Ab or detectable HIV RNA level)
  • No ART for at least previous 3 months
  • Ready to start or re-start ART (regimen pre-chosen by patient and provider)

Exclusion

  • Age \< 18 years, or \>60 years
  • Pregnancy
  • Current aspirin use
  • Presence of known atherosclerotic CVD determined by:
  • Previous myocardial infarction
  • Significant coronary atherosclerosis by angiography
  • Coronary revascularization procedure (coronary stent or surgical bypass)
  • Previous cerebral vascular accident (stroke)
  • Ischemic cardiomyopathy
  • Carotid stenosis (\>25% narrowing by carotid ultrasound)
  • Aortic aneurysm
  • Symptomatic peripheral vascular disease (claudication)
  • Surgical revascularization procedure of peripheral vessels
  • Hospitalization (within prior 2 weeks of study entry)
  • Concurrent self-limited bacterial infections (does not include chronic viral infections)
  • Clinical or pathologic diagnosis of systemic vasculitis
  • Active drug or alcohol use

Key Trial Info

Start Date :

October 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2010

Estimated Enrollment :

22 Patients enrolled

Trial Details

Trial ID

NCT00783614

Start Date

October 1 2008

End Date

June 1 2010

Last Update

November 21 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hennepin County Medical Center

Minneapolis, Minnesota, United States, 55415